Used as a key chiral intermediate in the synthesis of pharmaceutical agents, particularly in the development of kinase inhibitors for cancer treatment. Its structure enables selective binding to enzyme active sites, enhancing drug efficacy and specificity. Commonly employed in the production of investigational oncology drugs due to its favorable pharmacokinetic properties and ability to improve metabolic stability. Also utilized in the preparation of neuroprotective agents and anti-inflammatory compounds, where the (R)-enantiomer shows superior biological activity compared to its counterpart.